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RESPONSE TO THE LETTERCRP Predicts Safe Patient
Discharge after Colorectal
Surgery: Reply
Reply:
We would like to thank Aurelie´n Dupre`,Johan Gagnie´r, Heloı¨se Samba,
Michel Rivoire, and Karem Slim for their
comments about our article ‘‘Procalcitonin
Reveals Early Dehiscence in Colorectal
Surgery: The PREDICS Study.’’1 It is very
rewarding to realize that this paper is stim-
ulating so many observations, this means that
we are talking about an interesting topic.2
Thank you for underlining that PRE-
DICS is a large prospective observational
study, involving 3 high-volume colorectal
centers in Italy. It is to note that we described
study methods in our first preliminary paper3;
anyway, we are glad to share with you that
sample size was calculated for a difference of
at least 10% between the area under the
receiver operating characteristics (ROC)
curves (AUCs) of C-reactive protein (CRP)
and procalcitonin (PCT). In the pilot study,3
an AUC of 0.884 was observed for PCT at
third postoperative day and used for the
calculation. The prevalence of anastomotic
leakage was assumed to be 14% according to
the preliminary study, but was much lower in
the PREDICS study data (5.6%). Total num-
ber of patients to include was estimated to be
441. The study was designed to have 80%
power with an alpha error of 0.05.
Regarding strengthening the reporting
of observational studies in epidemiology
checklist,4 we decided not to publish it because
we consider it a useful tool only during study
design; anyway, in the ‘‘Materials and
methods’’ section, we carefully described all
study characteristics (inclusion and exclusion
criteria, variables reported in the database, andThe authors have no conflicts of interests to declare.
Copyright  2016 Wolters Kluwer Health, Inc. All
rights reserved.
ISSN: 0003-4932/14/26105-0821
DOI: 10.1097/SLA.0000000000001984
Annals of Surgery  Volume XX, Number X,
Copyright © 2016 Wolters KluwPositive and negative likelihood ratio
(PLR and NLR) for PCT in third and fifth
postoperative days (PODs) are, respectively:
7.14 and 0.44, and 9.9 and 0.33. For CRP, PLR
and NLR in third POD are 3.26 and 0.50, and
in fifth POD are 5.28 and 0.30, respectively.
According to these results, usefulness of pro-
calcitonin both in third and fifth POD is greater
than CRP, confirming the results previously
shown in our article with ROC curves. There-
fore, according to PREDICS outcomes,
together with this LR analysis, we keep stating
that PCTand CRP could be usefully added as a
diagnostic tool in early diagnosis of anasto-
motic leak (AL) in patients undergoing color-
ectal surgery for cancer. It should not
absolutely be a fight between the 2 bio-
markers, but a fight for better patient care.
So, because adding PCT to CRP in fifth POD
enhances AL diagnosis in a statistically sig-
nificant way, we are proud to keep stating that
this advantage is worth for patients’ life. In
fact, if the patient is discharged earlier and will
do well at home, we save money; on the
contrary, if AL is diagnosed early, it is possible
to avoid sepsis and late reoperation, and try to
pursue medical therapy saving money again,
and—most important—avoiding longer
hospital stay and worsening oncological out-
comes. We are all currently using tremen-
dously expensive technologies in the
operating room for laparoscopy and robotic
surgery, and nobody is questioning this huge
amount of money because it improves patient
outcomes. Why should we then discuss about
20 Euros more or less (10 Euro for each PCT
measurement) when patients’ quality of life
can be significantly improved?
The authors are stating, citing their own
work, that AL diagnosis is difficult, and we
absolutely agree to this conclusion. For this
reason, further research in this field is more
than welcome to give additional help to the
clinician and guide further diagnostic and thera-
peutic steps when biomarker levels are high.
Month 2016
er Health, Inc. Unauthorized repUsing biomarkers will never replace
the surgeon for anastomotic leak diagnosis,
but is a good help we should definitely accept
to use.
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